ARA 290 8mg
ARA-290 is a laboratory-grade research peptide chemical derived from the B-helix region of erythropoietin (EPO). Designed to selectively engage the EPOR–CD131 receptor complex, ARA-290 activates tissue-protective signaling pathways in experimental models without promoting red blood cell production. This peptide is a versatile tool for exploring cellular stress responses, inflammation pathways, and tissue protection in controlled laboratory studies.
Description
Overview
ARA-290 (cibinetide) is a synthetic peptide engineered from the helix-B surface of EPO. Unlike full-length erythropoietin, it is used strictly in laboratory research to investigate non-hematopoietic receptor signaling. Its structure allows researchers to study receptor-mediated tissue-protective effects, endothelial function, and immune-cell signaling in experimental settings.
Researchers can buy ARA-290 online to support in-vitro and in-vivo studies requiring reproducible peptide performance.
Research Applications
ARA-290 is commonly applied in research peptides workflows for studies such as:
- Cellular stress signaling and tissue-protective pathway analysis
- Immune-cell regulation, including cytokine activity and macrophage function
- Endothelial cell and tissue integrity studies
- Molecular and histological research in experimental models of inflammation and cellular homeostasis
Experimental systems typically include endothelial cell assays, immune-cell cultures, and rodent models, all under strict research conditions.
Purchase & Use
ARA-290 8 mg is available to order online as a research-use-only chemical for qualified laboratories, academic institutions, and educational research facilities. Researchers can order ARA-290 online for controlled, reproducible experimental research.
References (Scientific Context)
- Brines M et al., Proc Natl Acad Sci USA, 2008
- Ehrenreich H et al., Molecular Medicine, 2010
- Ostrowski D et al., PLoS One, 2017
You must be logged in to post a review.













Reviews
There are no reviews yet.